InvestSMART

Memphasys Limited (ASX:MEM)

ALERT: Price-sensitive ASX Announcement for MEM
Current share price for MEM : $0.006 -0.002 (-25%)+
Announcement
Release
16 Jul 2026 9:00AM
Price at Release
$0.008
Full Release
download
Summary
Memphasys Limited reported significant commercial activity for the quarter ended 30 June 2026, including record quarterly revenues of $150,000, a 34% increase from the previous quarter. The company executed its largest-ever Felix™ supply agreement with Monash IVF Group and expanded into the UK and Southeast Asia with new commercial agreements. Key achievements include a 71% reduction in quarterly operating cash outflows and the successful completion of a $1.2 million placement. The company's financial position was strengthened with cash on hand of $1,179,000, up significantly from the previous quarter, and expectations for further regulatory approvals in Vietnam, Turkey, and India to support sales growth. Memphasys also renewed its Board leadership with David Tasker appointed as Non-Executive Chairman.
Key Points
  • Record quarterly revenues of $150,000, up 34% from the previous quarter.
  • Executed largest-ever Felix™ supply agreement with Monash IVF Group.
  • Expanded market presence in the UK and Southeast Asia.
  • 71% reduction in quarterly operating cash outflows.
  • Successful completion of a $1.2 million placement.
  • Cash on hand increased to $1,179,000 from previous quarter.
  • Regulatory approvals expected in Vietnam, Turkey, and India.
  • Board leadership renewed with David Tasker as Non-Executive Chairman.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.